Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.

NCT01824251 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Inflammatory Demyelinating Polyneuropathy

Interventions

DRUG: NPB-01

Sponsor

Nihon Pharmaceutical Co., Ltd